obesity drug news today glp-1 oct 27 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Pipeline Update: August 2025
Description
Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive
Energy fluctuations linked to unstable blood sugar patterns
Methods A retrospective study was conducted using electronic medical records from 2014 to 2019 for adults with T2D at the Valencia Clnico-Malvarrosa Department of Health (Valencia, Spain)
GLP-1 RAs have gained attention for treating obesity and type 2 diabetes (T2DM), largely due to their ability to reduce gastric motility
